News & Updates
Filter by Specialty:
Novel agent plus ritonavir show favourable signals for mild-to-moderate COVID-19
10 Jul 2024
byAudrey Abella
A combination regimen comprising the novel agent GST-HG171 (also known as atilotrelvir) and ritonavir improves clinical symptom recovery and viral clearance in low-risk vaccinated adults with mild-to-moderate COVID-19, findings from a pivotal phase II/III study have shown.
Novel agent plus ritonavir show favourable signals for mild-to-moderate COVID-19
10 Jul 2024Lung cancer screening tied to reduced mortality
02 Jul 2024
byAudrey Abella
In an observational study conducted in Poland, individuals who participated in a low-dose computed tomography (LDCT) lung cancer screening programme had a reduction in all-cause mortality compared with a matched control group extracted from a general Polish cohort.